Actionable insights straight to your inbox

Equities logo

Reliq Health Technologies Corporate Update

Reliq Health is pleased to provide the following corporate update to current and future shareholders surrounding the recent developments at the Company.

Reliq Health Technologies Inc. (TSX VENTURE:RHT)(OTCQB:RQHTF) (“Reliq” or the “Company“),
a technology company focused on developing innovative mobile health
(mHealth) and telemedicine solutions for Community-Based Healthcare, is
pleased to provide the following corporate update to current and future
shareholders surrounding the recent developments at the Company.

Contracts and Pilot Programs

Reliq has launched a portfolio of remote patient monitoring,
care collaboration and telemedicine solutions and has secured the
following contracts and pilots:

  • Reliq has secured a contract with the Paz Home Health in
    McAllen, Texas that is expected to generate over US$6 million in
    recurring annual revenue by 2018. Under the terms of the contract, Reliq
    will provide its remote patient monitoring and care collaboration
    platform to Paz’s homecare providers and 10,000+ patients. The first 500
    patients are expected to go live on the platform in June 2017 ramping
    up to the full 10,000+ patient population by the end of Q1 2018,
    corresponding to recurring revenue of over US$500,000/month.
  • Reliq has also secured a contract with the City of
    San Antonio, Texas to provide a white-labelled version of Reliq’s
    platform to proactively support the health and wellness of the City’s
    1.4 million residents. The majority of the revenue from this contract is
    expected to be received between Q2 and Q4 2017.
  • The Company is currently piloting its software with
    the National Health Service (NHS) England at Imperial College Hospital,
    London, UK. The NHS is the largest single payer healthcare system
    worldwide, providing coverage for over 54 million UK residents. The
    pilot will end in Q3 2017.
  • Reliq has an ongoing pilot with Florida-based
    Sacred Heart Health System (a five-hospital regional healthcare
    network). Sacred Heart admits more than 30,000 patients annually and is a
    part of Ascension Health – the largest Catholic, non-profit health care
    system in the US and one of the largest global healthcare networks. The
    pilot will conclude in late Q2 2017.
  • The Company also has an ongoing pilot with The
    Feldman Institute in Baton Rouge, LA, an interventional pain management
    clinic that performs thousands of pain management surgeries annually.
    The pilot is expected to conclude in April 2017.
  • Reliq will be launching a pilot with Hamilton
    Health Sciences (HHS) in Hamilton, ON in April 2017. HHS is a
    five-hospital network that treats over 50,000 patients and performs over
    28,000 surgeries each year.

Cannabis Business Initiatives

  • Recently, Reliq signed a Memorandum of Understanding
    (MoU) with Invictus MD Strategies Corp. (IMH.CN) (IVITF) to provide Poda
    (an Invictus portfolio company) with an app its customers can use to
    track and manage their medical marijuana usage.
  • Reliq is building a secure clinical database
    designed to systematically anonymize, aggregate and analyze data
    collected from medical marijuana patients using Reliq’s patient apps.
    The anonymized clinical data will be used to statistically correlate
    variables such as dosage, strain and mode of administration with symptom
    relief and side effects. Ultimately this efficacy and safety data can
    be used to help identify the optimal strain and dosage for a given
    patient’s specific clinical condition.

Upcoming milestones in the next 6-12 months:

  • Reliq is focused on continuing to secure new contracts
    with home care agencies, assisted living facilities and hospitals in the
    United States and Canada
  • The Company expects to achieve profitability by the end of 2017

Cash Position

The Company has received $164,416 from the exercise of
warrants as of March 28, 2017. Additionally, due to investor interest
the Company intends to close a convertible debenture of up to $700,000,
subject to the TSX Venture Exchange approval. The Company’s CFO will
subscribe to $100,000 of this debenture. Subscribers of the debenture
have agreed to a voluntary hold period of 6 months.

Company Overview

Reliq Health Technologies is a healthcare technology company
that specializes in developing innovative software solutions for the
Community Care market. Reliq’s powerful iUGO Care platform supports care
coordination and community-based healthcare. The iUGO Care platform
integrates wearables, sensors, voice technology and intuitive mobile
apps and desktop user interfaces for patients, clinicians and healthcare
administrators. iUGO Care allows complex patients to receive high
quality care at home, improving health outcomes, enhancing quality of
life for patients and families and reducing the cost of care delivery.
Our platform provides real-time access to remote patient monitoring
data, allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health Technologies
trades on the TSX Venture under the symbol RHT and on the OTCQB as

“Dr. Lisa Crossley”
CEO and Director

Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this

Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute
forward-looking statements, within the meaning of applicable securities
laws. All statements that are not historical facts, including without
limitation, statements regarding future estimates, plans, programs,
forecasts, projections, objectives, assumptions, expectations or beliefs
of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve
known and unknown risks and uncertainties that could cause actual and
future events to differ materially from those anticipated in such

Forward-looking statements include, but are not limited to,
statements with respect to commercial operations, including technology
development, anticipated revenues, projected size of market, and other
information that is based on forecasts of future results, estimates of
amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“)
does not intend, and does not assume any obligation, to update these
forward-looking statements except as required by law. These
forward-looking statements involve risks and uncertainties relating to,
among other things, technology development and marketing activities, the
Company’s historical experience with technology development, uninsured
risks. Actual results may differ materially from those expressed or
implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

Contact Information

Renmark Financial Communications Inc.
Laura Welsh
[email protected]
(416) 644-2020 or (514) 939-3989

CORE Capital Partners
[email protected]

In the interest of full disclosure, we call the reader’s attention to the fact that, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

The Fed model compares the return profile of stocks and US government bonds.